Statins and Risk of Myocardial Infarction in Real Life in France

CompletedOBSERVATIONAL
Enrollment

13,171

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Myocardial Infarction
Trial Locations (56)

Unknown

Research Site, Ambilly

Research Site, Angers

Research Site, Arles

Research Site, Bagnols-sur-Cèze

Research Site, Bayonne

Research Site, Béziers

Research Site, Boulogne-sur-Mer

Research Site, Bourgoin

Research Site, Bron

Research Site, Cambo-les-Bains

Research Site, Cenon

Research Site, Châteauroux

Research Site, Clermont-Ferrand

Research Site, Colmar

Research Site, Crest

Research Site, Dijon

Research Site, Draguignan

Research Site, Eaubonne

Research Site, Firminy

Research Site, Forbach

Research Site, Fréjus

Research Site, Gleizé

Research Site, Grasse

Research Site, Guéret

Research Site, La Rochelle

Research Site, Langres

Research Site, Laon

Research Site, Le Coudray

Research Site, Le Mans

Research Site, Le Puy-en-Velay

Research Site, Mayenne

Research Site, Millau

Research Site, Montélimar

Research Site, Montfermeil

Research Site, Montpellier

Research Site, Nîmes

Research Site, Orange

Research Site, Orléans

Research Site, Paris

Research Site, Pau

Research Site, Perpignan

Research Site, Puilboreau

Research Site, Rueil-Malmaison

Research Site, Rumilly

Research Site, Saint Amand Monrond

Research Site, Saint Jean Des Verges

Research Site, Saint-Estève

Research Site, Sallanches

Research Site, Salon-de-Provence

Research Site, Sens

Research Site, Thonon-les-Bains

Research Site, Toulouse

Research Site, Tours

Research Site, Tulles

Research Site, Valence

Research Site, Villefranche-de-Rouergue

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY